Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
Xconomy
JANUARY 4, 2019
In 2018, my Exome colleagues and I published hundreds of stories about health, medicine, the biopharma industry, government policy, and more. You’ll find a few of our favorite stories in this review of some of the year’s best from across the Xconomy network.
Let's personalize your content